// App-Quantinova.ai

P1130 : ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY

Researchers

Presenter

  • Roger Owen

Principal Investigators

  • Helen McCarthy

  • Simon Rule

  • Shirley D'Sa

  • Sheeba Thomas

  • Oliver Tournilhac

  • Francesco Forconi

  • Marie Jos Kersten

  • Pier Luigi Zinzani

  • Sunil Iyengar

  • Jaimal Kothari

  • Monique Minnema

  • Efstathios Kastritis

  • Bruce Cheson

  • Harriet Walter

  • Roser Calvo

  • Richard Furman

Medical Centers

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • Georgetown University Hospital, Lombardi Comprehensive Cancer Center,Washington, DC,Stati Uniti

  • Plymouth University Medical School, Plymouth,Verenigd Koninkrijk

  • University of Southampton Hospital Trust, Southampton, United Kingdom

  • MD Anderson Cancer Center ,Houston,Verenigde Staten

  • Churchill Hospital,Oxford,Regno Unito

  • AstraZeneca, Gaithersberg, MD, United States,

  • University of Southampton Hospital Trust, Southampton, United Kingdom

  • Churchill Hospital,Oxford,Соединённое Королевство

  • National and Kapodistrian University of Athens, Athens, Greece

  • Royal Bournemouth Hospital, Bournemouth, United Kingdom

  • St. James University Hospital,Leeds,Vereinigtes Königreich

  • University Medical Center Utrecht, University Medical Center Utrecht, Netherlands

  • Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam,Amsterdam,Pays-bas

  • Georgetown University Hospital, Lombardi Comprehensive Cancer Center,Washington, DC,Stati Uniti

  • Royal Marsden Hospital, London,

  • St. James's University Hospital, Leeds, United Kingdom

  • MD Anderson Cancer Center ,Houston,Verenigde Staten

  • University Medical Center Utrecht, University Utrecht, Utre

  • AstraZeneca,South San Francisco,Vereinigte Staaten

  • Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam,Amsterdam,Pays-bas

  • Institute of Hematology University

  • National and Kapodistria

  • National and Kapodistrian University of Athens, Athens, Greece

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • AstraZeneca,South San Franc

  • Cancer Center of Santa Barbara, Santa Barbara, CA

  • Hematology,University College London Hospitals (UCLH) NHS Foundation Trust,London,Royaume-uni

  • St James's University Hospital,Leeds,Royaume-uni

  • Royal Bournemouth Hospital,Bournemouth,Vereinigtes Königreich

  • Plymouth University Medical School, Plymouth, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

  • AstraZeneca,Gaithersburg,États-unis

  • Royal Marsden Hospital,Sutton,Regno Unito

  • Georgetown University Hospital, Lombardi Comprehensive Cancer Center,Washington, DC,Stati Uniti

  • Royal Bournemouth Hospital,Bournemouth,Regno Unito

  • Royal Bournemouth Hospital,Bournemouth,Royaume-uni

  • St. James's University Hospital,Leeds,Reino Unido

  • AstraZeneca,Gaithersburg, MD,Verenigde Staten

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • AstraZeneca,Gaithersburg, MD,Verenigde Staten

  • St. James's University Hospital,Leeds,Reino Unido

  • Royal Bournemouth Hospital,Bournemouth,Regno Unito

  • AstraZeneca,Gaithersburg,Estados Unidos

  • AstraZeneca, Gaithersburg, MD

  • Plymouth University Medical School, Plymouth,Verenigd Koninkrijk

  • on behalf of the Lunenburg Lymphoma Phase I/II Consortium – HOVON/LLPC,Utrecht,Niederlande

  • AstraZeneca, South San Francisco,California,Estados Unidos

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • Royal Bournemouth Hospital

  • Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • St. James University Hospital,Leeds,Vereinigtes Königreich

  • Ernest and Helen Scott Haematological Research Institute and Leicester Cancer Research Centre, University o

  • Churchill Hospital, Oxford, United Kingdom

  • Churchill Hospital,Oxford,Storbritannien

  • University College London Hospitals NHS Trust, London, United Kingdom

  • on behalf of the Lunenburg Lymphoma Phase I/II Consortium – HOVON/LLPC,Utrecht,Niederlande

  • University of Southampton,Southampton,Vereinigtes Königreich

  • MD Anderson Cancer Center,Houston, TX,Estados Unidos

  • University College London Hospitals NHS Trust, London, United Kingdom

  • MD Anderson Cancer Center,Houston, TX,Estados Unidos

  • Cancer Center of Santa Barbara,Santa Barbara,United States

  • St. James's University Hospi

  • Cancer Center of Santa Barbara,Santa Barbara,United States

  • Plymouth University Medical School, Plymouth, United Kingdom

  • Cancer Center of Santa Barbara,Santa Barbara,Estados Unidos

  • AstraZeneca, South San Francisco,California,Estados Unidos

  • Georgeto

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • Amsterdam University Medical Centers, University of Amsterdam, Cancer Center

  • Plymouth University Medical School,Plymouth,Royaume-uni

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • Plymouth University Medical School,

  • Cancer Center of Santa Barbara, Santa Barbara, CA

  • Churchill Hospital,Oxford,Royaume-uni

  • University College London Hospitals NHS Foundation Trust,London,Vereinigtes Königreich

  • University of Southampton Hospital Trust, Southampton, United Kingdom

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • Royal Bournemouth Hospital,Bournemouth,Vereinigtes Königreich

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • AstraZeneca, South San Francisco,California,Estados Unidos

  • Churchill Hospital, Headington,Oxford,Verenigd Koninkrijk

  • Cancer Center of Santa Barbara, Santa Barbara, CA

  • MD Anderson Cancer Center,Houston, TX,Estados Unidos

  • University of Southampton Hospital Trust, Southampton, United Kingdom

  • Ernest and Helen Scott Haematological Research Institute and Leicester Cancer Research Centre, University o

  • Royal Marsden Hospital,London,Vereinigtes Königreich

  • Plymouth University Medical School, Plymouth, United Kingdom

  • National and Kapodistrian University of Athens, Athens, Greece

  • The Royal Marsden Hospital, London, United Kingdom

  • Weill Cornell Medical College, New York, NY

  • Churchill Hospital,Oxford,Regno Unito

  • National and Kapodistrian University of Athens, Athens, Greece

  • Cancer Center of Santa Barbara,Santa Barbara,United States

  • Royal Marsden Hospital,London,Соединённое Королевство

  • Royal Marsden Hospital,Sutton,Regno Unito

  • University of Southampton,Southampton,Royaume-uni

  • 1.MD Anderson Cancer Center, Houston, TX

  • AstraZeneca,South San Francisco, CA,United States

  • AstraZeneca,Gaithersburg,Stati Uniti

  • Royal Marsden Hospital,London,Vereinigtes Königreich

  • Ernest and Helen Scott Haematological Research Institute and Leicester Cancer Research Centre, University o

  • Haematologiy,Royal Free Hospital,London,Royaume-uni

  • National and Kapodistrian University of Athens, Athens, Greece

  • AstraZeneca,South San Francisco,Vereinigte Staaten

  • Churchill Hospital, Headington,Oxford,Vereinigtes Königreich

  • Amsterdam University Medical centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands

  • Institute of Hematology, University of Bologna, Bologna, Italy

Locations

  • United Kingdom

  • United States

  • Italy

  • Netherlands

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • ACP-196

Outcome

  • N/A

Study Design

  • Single Arm

  • Multinational

  • Multicenteric

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved